Edith A. Perez

This article includes a list of general references, but it remains largely unverified because it lacks sufficient corresponding inline citations. Please help to improve this article by introducing more precise citations. (February 2022) (Learn how and when to remove this template message)

Edith Álvarez Pérez is a Puerto Rican hematologist-oncologist. She is the Serene M. and Frances C. Durling Professor of Medicine at the Mayo Clinic Alix School of Medicine.^[1]

Early life and education[]

Perez was born and raised in Humacao, Puerto Rico. Her mother was a teacher and librarian and her father owned a grocery store. During her freshman year at University of Puerto Rico, Río Piedras Campus, Perez's grandmother died. Her death motivated her to become a physician. In 1975, she graduated magna cum laude with a B.S. in Biology.^[2]

Perez completed a M.D. at the University of Puerto Rico School of Medicine. She completed her residency in internal medicine at the Loma Linda University Medical Center.^[1] Perez conducted a fellowship in hematology and oncology at the Martinez VA Medical Center through the UC Davis School of Medicine.^[1]

Career[]

Perez joined Bolt Biotherapeutics in 2020 as its Chief Medical Officer. She brought her two decades of academic experience at the Mayo Clinic and her established leadership in the oncology community with her to Bolt. She will maintain her academic affiliation as Professor of Medicine with Mayo Clinic. She will also maintain leadership roles in various non-profit organizations, including The Donna Foundation and Stand Up to Cancer.^[3]

Her career at Mayo Clinic has contributed to her academic excellence, global engagement in research and education, and compassion for patients. Perez became Director of the Mayo Clinic Breast Cancer Translational Genomics Program in 2009. She has also served as Full Professor of Medicine at Mayo Clinic since 2001, an appointment to which she was promoted after working as an Assistant and then Professor at Mayo Clinic. Perez has also been a Supplemental Consultant in the Department of Hematology/Oncology and Cancer Biology at Mayo Clinic since 2015.

Perez has served as principal investigator in the development and execution of a wide range of clinical trials exploring the use of new therapeutic agents for the treatment and prevention of breast cancer. These clinical trials highlighted the need for basic research studies to evaluate the role of genetic markers in the development and aggressiveness of breast cancer. Her leadership in spearheading these basic research studies has helped advance an understanding of biomarkers' prognostic and predictive applicability.

Perez also has served on the editorial boards of and as a reviewer for multiple journals. She has authored more than 400 peer-reviewed articles.

She worked as the Vice president and Head of the BioOncology-U.S. Medical Affairs unit at Genentech from 2015 to 2018, where she led the development and conduct of translational studies with registrational intent, including engaging in discussions with the FDA. Her activities those years also included membership at the Genentech/Roche Cancer Immunotherapy Governance Committee.

Perez is also the co-developer of the 26.2 National Marathon to Finish Breast Cancer, which raises funds for under-served women and for genomics and immunologic translational cancer research.

Personal life[]

Perez is lesbian.^[3]

References[]

• "Edith A. Perez, M.D. - Mayo Clinic Faculty Profiles - Mayo Clinic Research". Retrieved October 29, 2014.
• "Cancer Center Departments and Centers - Mayo Clinic Cancer Center - Mayo Clinic". Retrieved October 29, 2014.
• "Alliance - Board of Directors". Retrieved October 29, 2014.
• "Perez EA - PubMed – NCBI". Retrieved October 29, 2014.
• "Breast Cancer Marathon". Retrieved October 29, 2014.
• "Mayo Clinic Oncologist and MD Anderson Researcher Named 2013 Susan G. Komen Brinker Awardees for Scientific Distinction - Susan G. Komen". September 11, 2013. Retrieved October 29, 2014.
• "Edith A. Perez, MD - Giants of Cancer Care". Retrieved October 29, 2014.
• "Board of Directors". Retrieved September 3, 2015.